Close Menu
Home » FDA, CancerLinQ to Track Real-World Targeted Therapy Use, Starting With Melanoma Drugs

FDA, CancerLinQ to Track Real-World Targeted Therapy Use, Starting With Melanoma Drugs

Jun 05, 2017
|
Molika Ashford

CHICAGO (GenomeWeb) – The American Society for Clinical Oncology announced this week that it has added two new long-term partners to its big-data initiative CancerLinQ, one of which is the US Food and Drug Administration.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

New Privacy Coalition

Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.

Less Sweat, More Diverse Microbiome

University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.

Oh, This Code

The Wall Street Journal examines billing codes used by uBiome.

PNAS Studies Look at Lung Cancer LncRNA, Hi-C Clustering, and More

In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.

What's Popular?

In Informatics

  1. FDNA, PerkinElmer Form Genetic Testing Technology Alliance

  2. Pediatric Cancer Big Data Initiatives Could Help Set Best Practices for Sequencing, Data Sharing

    Premium

  3. As Million European Genomes Initiative Advances, Alliance Promotes New Personalized Medicine Project

    Premium

  4. University of Liverpool, Liverpool School of Tropical Medicine Win $4.5M Antimicrobial Resistance Grant

  5. Helomics, ChemImage Partner on Prostate Cancer Monitoring Tech Development

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.